Pregnancy is associated with the rapid growth of PAVMs due to hormonal and hemodynamic consequences with a higher risk of complications from lack of filtration and rupture [9]. Treatment of PAVMs involves endovascular occlusion of the feeding artery and in rare instances surgical resection. Percutaneous transcatheter embolization is typically performed for the treatment of PAVMs. The feeding artery is occluded by an embolic device obliterating the arteriovenous shunt. Regardless of the size of the feeding artery, any PAVM detected by CT or catheter angiography should be considered for treatment due to the risk of paradoxical embolism [10,11]. Embolization is performed by deploying coils or plugs in the feeding artery as close to the aUT Southwestern Medical Center, Dallas, Texas. bPanel Chair, Brigham & Women's Hospital, Boston, Massachusetts. cPanel Vice-Chair, Brigham & Women's Hospital, Boston, Massachusetts. dUniversity of Toronto, Toronto, Ontario, Canada; American College of Physicians. eKnight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon; Society of Cardiovascular Computed Tomography. fUT Southwestern Medical Center, Dallas, Texas; Commission on Nuclear Medicine and Molecular Imaging. gOchsner Hospital, Baton Rouge, Louisiana. hUniversity of California San Francisco, San Francisco, California. iUniversity of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. jWilmington Health, Wilmington, North Carolina; American College of Chest Physicians. kCleveland Clinic, Cleveland, Ohio. lUCLA Medical Center, Los Angeles, California; The Society of Thoracic Surgeons. mVA Puget Sound Health Care System and University of Washington, Seattle, Washington. nThe Warren Alpert School of Medicine at Brown University, Providence, Rhode Island; Nuclear cardiology expert. oSouth Texas Radiology Group, P.A., San Antonio, Texas. pMercyhealth, Rockford, Illinois. qLahey Hospital and Medical Center, Burlington, Massachusetts.
Pulmonary Arteriovenous Malformation PAVM . Pregnancy is associated with the rapid growth of PAVMs due to hormonal and hemodynamic consequences with a higher risk of complications from lack of filtration and rupture [9]. Treatment of PAVMs involves endovascular occlusion of the feeding artery and in rare instances surgical resection. Percutaneous transcatheter embolization is typically performed for the treatment of PAVMs. The feeding artery is occluded by an embolic device obliterating the arteriovenous shunt. Regardless of the size of the feeding artery, any PAVM detected by CT or catheter angiography should be considered for treatment due to the risk of paradoxical embolism [10,11]. Embolization is performed by deploying coils or plugs in the feeding artery as close to the aUT Southwestern Medical Center, Dallas, Texas. bPanel Chair, Brigham & Women's Hospital, Boston, Massachusetts. cPanel Vice-Chair, Brigham & Women's Hospital, Boston, Massachusetts. dUniversity of Toronto, Toronto, Ontario, Canada; American College of Physicians. eKnight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon; Society of Cardiovascular Computed Tomography. fUT Southwestern Medical Center, Dallas, Texas; Commission on Nuclear Medicine and Molecular Imaging. gOchsner Hospital, Baton Rouge, Louisiana. hUniversity of California San Francisco, San Francisco, California. iUniversity of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. jWilmington Health, Wilmington, North Carolina; American College of Chest Physicians. kCleveland Clinic, Cleveland, Ohio. lUCLA Medical Center, Los Angeles, California; The Society of Thoracic Surgeons. mVA Puget Sound Health Care System and University of Washington, Seattle, Washington. nThe Warren Alpert School of Medicine at Brown University, Providence, Rhode Island; Nuclear cardiology expert. oSouth Texas Radiology Group, P.A., San Antonio, Texas. pMercyhealth, Rockford, Illinois. qLahey Hospital and Medical Center, Burlington, Massachusetts.